Abstract
A 56-year-old woman with Hodgkin-like adult T-cell leukemia/lymphoma was treated with allogeneic peripheral blood stem cell transplantation on 17 April 2009. She manifested a moderate fever on day 41. CT scanning and other examinations detected slightly swollen lymph nodes, and pathological findings of right axillary lymph nodes revealed an Epstein-Barr virus-associated post-transplant lymphoproliferative disorder. She was successfully treated with rituximab.
MeSH terms
-
Antibodies, Monoclonal, Murine-Derived / therapeutic use
-
Antineoplastic Agents / therapeutic use
-
Epstein-Barr Virus Infections / complications*
-
Epstein-Barr Virus Infections / pathology
-
Female
-
Hematopoietic Stem Cell Transplantation*
-
Humans
-
Leukemia-Lymphoma, Adult T-Cell / therapy*
-
Lymph Nodes / pathology
-
Lymph Nodes / virology
-
Lymphoproliferative Disorders / drug therapy
-
Lymphoproliferative Disorders / pathology
-
Lymphoproliferative Disorders / virology*
-
Middle Aged
-
Rituximab
-
Transplantation, Homologous
Substances
-
Antibodies, Monoclonal, Murine-Derived
-
Antineoplastic Agents
-
Rituximab